Solid Biosciences Inc.
Hedge Funds Holdings
Last updated:
Solid Biosciences Inc.‘s stocks are currently a part of 18 hedge funds’ portfolios, which represents 19.82% of the total amount of its stocks outstanding. This makes up a total of 1.68M shares of Solid Biosciences Inc.. Compared to the previous quarter, the number fell by -88.98% or -13.62M shares fewer. As for the holding position changes, 22.22% (4) of current hedge fund investors increased the number of shares held, 27.78% (5) of current holders sold a part of the shares held, and 16.67% (3) closed the holdings completely. 4 hedge funds are new holders of Solid Biosciences Inc. stock in Q1 2023, it is 22.22% of total holders.
Hedge funds holding Solid Biosciences (Q2 2018 – Q1 2023)
Q2 2018 | 65 |
---|---|
Q3 2018 | 77 |
Q4 2018 | 75 |
Q1 2019 | 75 |
Q2 2019 | 74 |
Q3 2019 | 69 |
Q4 2019 | 70 |
Q1 2020 | 72 |
Q2 2020 | 66 |
Q3 2020 | 61 |
Q4 2020 | 75 |
Q1 2021 | 104 |
Q2 2021 | 91 |
Q3 2021 | 87 |
Q4 2021 | 80 |
Q1 2022 | 74 |
Q2 2022 | 61 |
Q3 2022 | 52 |
Q4 2022 | 34 |
Q1 2023 | 18 |
Hedge funds changes in Solid Biosciences positions (Q2 2018 – Q1 2023)
Q2 2018 | 21 | 21 | 13 | 12 | -2 |
---|---|---|---|---|---|
Q3 2018 | 20 | 32 | 12 | 8 | 5 |
Q4 2018 | 20 | 29 | 17 | 22 | -13 |
Q1 2019 | 23 | 25 | 15 | 23 | -11 |
Q2 2019 | 22 | 22 | 14 | 19 | -3 |
Q3 2019 | 12 | 34 | 12 | 17 | -6 |
Q4 2019 | 18 | 26 | 14 | 17 | -5 |
Q1 2020 | 14 | 22 | 22 | 11 | 3 |
Q2 2020 | 11 | 22 | 20 | 17 | -4 |
Q3 2020 | 6 | 17 | 23 | 11 | 4 |
Q4 2020 | 25 | 33 | 11 | 11 | -5 |
Q1 2021 | 40 | 32 | 21 | 11 | 0 |
Q2 2021 | 13 | 37 | 22 | 26 | -7 |
Q3 2021 | 13 | 22 | 30 | 16 | 6 |
Q4 2021 | 10 | 32 | 18 | 16 | 4 |
Q1 2022 | 11 | 13 | 34 | 17 | -1 |
Q2 2022 | 15 | 10 | 22 | 26 | -12 |
Q3 2022 | 5 | 12 | 17 | 14 | 4 |
Q4 2022 | 34 | 0 | 0 | 50 | -50 |
Q1 2023 | 4 | 4 | 5 | 3 | 2 |
Hedge funds changes in Solid Biosciences stock options (Q2 2018 – Q1 2023)
Q2 2018 | 0 | 0 |
---|---|---|
Q3 2018 | 271,000 | 0 |
Q4 2018 | 3,642,000 | 6,444,000 |
Q1 2019 | 6,210,000 | 3,001,000 |
Q2 2019 | 3,407,000 | 1,266,000 |
Q3 2019 | 5,436,000 | 5,688,000 |
Q4 2019 | 3,359,000 | 2,713,000 |
Q1 2020 | 1,616,000 | 782,000 |
Q2 2020 | 182,000 | 182,000 |
Q3 2020 | 9,000 | 3,000 |
Q4 2020 | 5,238,000 | 1,534,000 |
Q1 2021 | 5,350,000 | 2,089,000 |
Q2 2021 | 1,104,000 | 748,000 |
Q3 2021 | 567,000 | 527,000 |
Q4 2021 | 47,000 | 176,000 |
Q1 2022 | 120,000 | 19,000 |
Q2 2022 | 65,000 | 12,000 |
Q3 2022 | 72,000 | 9,000 |
Q4 2022 | 215,938 | 5,380 |
Q1 2023 | 0 | 4,740,000 |